Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record.

A strategy for discovery of cancer glyco‐biomarkers in serum using newly developed technologies for glycoproteomics

Narimatsu, Hisashi, Sawaki, Hiromichi, Kuno, Atsushi, Kaji, Hiroyuki, Ito, Hiromi, Ikehara, Yuzuru·2010·The FEBS Journal

Abstract

Detection of cancer at early stages that can be treated through surgery is a difficult task. One methodology for cancer biomarker discovery exploits the fact that glycoproteins produced by cancer cells have altered glycan structures, although the proteins themselves are common, ubiquitous, abundant, and familiar. However, as cancer tissue at the early stage probably constitutes less than 1% of the normal tissue in the relevant organ, only 1% of the relevant glycoproteins in the serum should have altered glycan structures. Here, we describe our strategy to approach the detection of these low‐level glycoproteins: (a) a quantitative real‐time PCR array for glycogenes to predict the glycan structures of secreted glycoproteins; (b) analysis by lectin microarray to select lectins that distinguish cancer‐related glycan structures on secreted glycoproteins; and (c) an isotope‐coded glycosylation site‐specific tagging high‐throughput method to identify carrier proteins with the specific lectin epitope. Using this strategy, we have identified many glycoproteins containing glycan structures that are altered in cancer cells. These candidate glycoproteins were immunoprecipitated from serum using commercially available antibodies, and their glycan alteration was examined by a lectin microarray. Finally, they were analyzed by multistage tandem MS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1742-4658.2009.07430.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 169

Metadata

Authors
Narimatsu, H., Sawaki, H., Kuno, A., Kaji, H., Ito, H., & Ikehara, Y.
Venue
The FEBS Journal
Publisher
Wiley
Published
2009-12-15
Volume
277
Issue
1
Pages
95-105
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W2118054188
Cited by
169
References
0
FWCI
5.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A strategy for discovery of cancer glyco‐biomarkers in serum using newly developed technologies for glycoproteomics. https://app.cochat.ai/papers/10.1111/j.1742-4658.2009.07430.x
The paper
Narimatsu, H., Sawaki, H., Kuno, A., Kaji, H., Ito, H., & Ikehara, Y. (2010). A strategy for discovery of cancer glyco‐biomarkers in serum using newly developed technologies for glycoproteomics. The FEBS Journal. https://doi.org/10.1111/j.1742-4658.2009.07430.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.